Pre-formulation studies

API-excipient compatibility

share on
mercoledì 22 aprile 2015

In addition to API, a pharmaceutical dosage form contains excipients which can affect the chemical, physical and therapeutical properties, product stability and may even cause a change in the API polymorphic form.

Estimation of API-excipient interactions is a crucial step in preformulation studies of drug development to achieve a robust and effective formulation of dosage forms that make administration easier, improve patient compliance, promote release and bioavailability of the drug and increase its shelf life.

How can we help you?

  • Obtain an in-depth understanding of physical or chemical API-excipient interactions
  • Support the selection of the most appropriate excipients in dosage form design

© Copyright Polycrystalline SpA - All rights reserved - VAT IT02600021204 / powered by DibiWeb